Global EGFR Mutation Test Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global EGFR Mutation Test Market 2024 by Company, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global EGFR Mutation Test market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.

Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.

The Global Info Research report includes an overview of the development of the EGFR Mutation Test industry chain, the market status of Cancer Hospitals (DNA Sequencing, Kits), Clinical Research Institutes (DNA Sequencing, Kits), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of EGFR Mutation Test.

Regionally, the report analyzes the EGFR Mutation Test markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global EGFR Mutation Test market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the EGFR Mutation Test market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the EGFR Mutation Test industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., DNA Sequencing, Kits).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the EGFR Mutation Test market.

Regional Analysis: The report involves examining the EGFR Mutation Test market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the EGFR Mutation Test market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to EGFR Mutation Test:

Company Analysis: Report covers individual EGFR Mutation Test players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards EGFR Mutation Test This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer Hospitals, Clinical Research Institutes).

Technology Analysis: Report covers specific technologies relevant to EGFR Mutation Test. It assesses the current state, advancements, and potential future developments in EGFR Mutation Test areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the EGFR Mutation Test market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

EGFR Mutation Test market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
DNA Sequencing
Kits

Market segment by Application
Cancer Hospitals
Clinical Research Institutes

Market segment by players, this report covers
Abbott
Merck
Thermo Fisher Scientific
Illumina
BioMerieux
QIAGEN
Agilent Technologies
Hologic
Novartis
Roche
Genomic Health

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe EGFR Mutation Test product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of EGFR Mutation Test, with revenue, gross margin and global market share of EGFR Mutation Test from 2019 to 2024.

Chapter 3, the EGFR Mutation Test competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and EGFR Mutation Test market forecast, by regions, type and application, with consumption value, from 2025 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of EGFR Mutation Test.

Chapter 13, to describe EGFR Mutation Test research findings and conclusion.